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Background: Endovenous laser ablation (EVLA) is a minimally invasive technique for treating great saphenous vein
(GSV) reflux for several years. We report our experience with EVLA and evaluate its effectiveness.
Methods: A consecutive series of patients (639 women [60%] and 421 men [40%], age 23 to 79 years) were treated by
EVLA for GSV reflux and tributary varices at our institution. A questionnaire was used to assess preoperative and
postoperative symptoms. The primary outcomes for assessing safety were mortality andmorbidity, including laser-related
adverse events, postoperative infection, thrombotic events, etc. Effectiveness was assessed by the obliteration of the vein,
disappearance of varicosities, and so on.
Results: All patients tolerated the procedure well, recovered uneventfully, and returned to daily activities and work 3 days
and 10 to 14 days, respectively, after the operation. Treatment with EVLA plus ligation of the GSV resulted in occlusion
in all cases at 2 weeks follow-up and in 1169 of 1186 (99%) at 6-month follow-up; the rate of retreatment was low
(36/1186). Complications were minor and improved quickly.
Conclusions: EVLA can reduce and relieve symptoms associated with varicose veins and achieve cosmetic goals. Vein
emptying before exposure to laser energy and compression treatment afterwards may improve results. ( J Vasc Surg 2008;
48:675-9.)Varicose veins are common in men (prevalence, 10.4%
to 23.0%) and women (29.5% to 39.0%).1,2 Inmost people,
varicose veins are associated with aching, itching, heavy
legs, edema, lipodermatosclerosis, or even frank ulceration,
and some people, especially young patients, seek treatment
for cosmetic goals because they find varicose veins un-
sightly.
Great saphenous vein (GSV) reflux is the most com-
mon underlying cause of symptomatic varicose veins. Tra-
ditional treatment of GSV reflux has been surgical removal
of the GSV. Tributary varicosities require multiple phlebec-
tomy or follow-up treatment with sclerotherapy. Although
surgical ligation and stripping of the GSV has been the
most dependable treatment, it is associated with significant
perioperative morbidity. There are recognized morbidities
associated with surgery, and patients require 2 to 3 weeks to
return to normal activity. Potential complications include
cutaneous neurosensory loss, wound infection, hematoma,
and, more rarely, lymph leak and deep vein thrombosis.
Despite improvements in technique, recurrence remains a
problem after surgery.3,4 In view of these less than satisfac-
tory outcomes and to reduce morbidity and recovery time,
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doi:10.1016/j.jvs.2008.04.017minimally invasive techniques have been developed as al-
ternatives to conventional surgery in recent years. En-
dovenous laser ablation (EVLA) is the most promising of
these new techniques. However, most surgeons only use
endovenous laser ablation for GSV reflux because they
believe tributary varicosities cannot be treated with EVLA
and will require follow-up treatment with sclerotherapy or
multiple phlebectomy sometimes.5,6
From June 2001 to April 2006, 1060 patients were
successfully treated by EVLA in our hospital. This report
recounts our experiences with EVLA in the treatment of
GSV reflux and tributary varices and evaluates the effective-
ness of this treatment option.
METHODS
Patient selection. This is a retrospective, consecutive-
enrollment study of patients receiving endovenous laser
ablation for incompetent GSV and tributary varices. Di-
rected history and physical examination, including duplex
ultrasound (US) evaluation of the superficial and deep
venous system, were performed on limbs of subjects with
varicose veins. Duplex ultrasound was performed in the
upright position to map incompetent sources of venous
reflux. Venous reflux was defined as reverse flow of more
than 0.5 seconds.7 Ascending venography was performed
to confirm the diagnosis and further exclude postthrom-
botic syndrome with total recanalization and the May-
Thurner syndrome, which may be missed on ultrasonogra-
phy. Presence of incompetent perforators was not routinely
evaluated.
Study inclusion criteria included varicose veins caused
by saphenofemoral junction (SFJ) incompetence with GSV
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least 20 years; completed written informed consent form
acknowledging awareness of the alternative treatments
available, risks involved, and other issues that conform to
the standard of care for informed consent practices; and
ability to return for scheduled follow-up examinations for
at least 12 months after EVLA. Exclusion criteria included
nonpalpable pedal pulses; inability to ambulate; previous
deep venous thrombosis; theMay-Thurner syndrome; con-
genital malformations; axial deep venous reflux, from groin
through popliteal vein; general poor health; pregnancy, or
plans to become pregnant during the course of participa-
tion in the investigation; acute superficial thrombophlebi-
tis, and venous ulceration larger than 2.0 cm in diameter.
Description of the technique. All patients were
treated by EVLA combined with high ligation of the GSV in
accordance with a four-step standard protocol. In the first
step, the GSV was disconnected from and ligated at the
saphenofemoral junction (SFJ). In the second step, the GSV
was punctured at the ankle level with an 18-gauge needle
under ultrasound-guidance or after wrapping a strip above the
ankle to achieve hemostasis. A 5F introducer sheath (Cook,
Bloomington, Ind) was placed into the GSV; a catheter was
inserted into the distal GSV and advanced to the SFJ using
a 0.035-inch diameter J guidewire. If catheter could not be
advanced to the SFJ, it would be inserted from the GSV
stump to ankle level using a 0.035-inch diameter J guide-
wire. In the third step, the varicose branches were punc-
tured using an 18-gauge needle, and the intraluminal po-
sition of the needle within the varicosities was confirmed by
aspiration of nonpulsatile venous blood. A 0.035-inch di-
ameter mini guidewire was placed into the varicose vein,
and a 5F introducer dilator was inserted as far as possible. A
laser fiber was then inserted in the dilator and the dilator
was withdrawn. The laser was fired as it was withdrawn at a
rate of 1-3 mm/s with manual pressure being applied to
achieve venous wall apposition around the laser fiber tip.
The laser fiber was directly inserted and fired if the mini
guidewire and dilator could not be placed into the tributary
varices, and the treated area would be compressedmanually
several minutes. If varicosities were very close or adhered to
the dermis, then subcutaneous injection of tumescent sa-
line over the treated vein was indicated, to form a protective
barrier between varicosities and the skin. This compressed
the vein to ensure vein wall apposition to the fiber and
limited heat conduction to perivenous tissues, thus mini-
mizing the possibility of heat-related damage to adjacent
tissues.8 Quick withdrawal was important as well. In the
fourth step, a laser fiber was inserted via a catheter into
the distal GSV and advanced to the SFJ. The tip position of
the laser fiber was confirmed by direct visualization of its
red aiming beam through the skin and GSV stump. The
catheter was then withdrawn 3 cm, exposing the distal end
of the bare-tipped laser fiber and positioning it 1-2 cm
below the GSV stump. The wound was cleaned and
dressed, and a near bloodless field in the vein (to be treated)
was created by wrapping the limb with elastic compressive
bandage and placing the patient in the Trendelenburgposition. The catheter and optical fiber were pulled back
together from the proximal GSV stump, preferably at a rate
of 1-2 mm second (a retraction speed that is adaptable to
changes in the venous diameter and inner vessel surface).
The energy of the laser beam was 12 watts, and exposures
were either pulsed (1-second pulses separated by 1-second
intervals during withdrawal) or continuous as the fiber was
withdrawn. If the GSV was too tortuous to allow a catheter
to pass, multiple puncture was indicated, and ultrasound-
guided catheterization was used if necessary.
Antibiotics were used for 1 to 3 days and anticoagulants
for one time routinely after operation in order to avoid
infection and deep venous thrombosis. A compression ban-
dage was worn at least for 3 days following treatment, and
a class II (30-40 mm Hg) full-thigh graduated support
stocking or panty hose was worn for at least 1 month at all
times during follow-up, except to sleep or to shower.
Patients were instructed to ambulate and resume their
normal daily activities as soon as possible after treatment.
Two weeks after EVLA, patients returned for follow-up.
Physical examination of the treated area, bidirectional
Doppler and duplex US examinations were performed to
check for GSV occlusion. Similar evaluations were per-
formed at each follow-up visit. Clinical and duplex US
follow-up was obtained at 2 weeks, 3, 6, and 12 months,
and then yearly. Tumescent anesthetic solution was not
routinely injected around the saphenous vein before treat-
ment in this series.
Study endpoints and definitions. The primary out-
comes for assessing safety were mortality and morbidity,
including laser-related adverse events, postoperative infec-
tion, thrombotic events, pain, skin burn injury, leg swell-
ing, bleeding complications, ecchymosis, paraesthesia,
induration, and phlebitis. Effectiveness was assessed by
evaluating the obliteration of the vein, disappearance of
varicosities, rate of retreatment, reduction of symptoms and
pigmentation, or other skin changes secondary to chronic
venous insufficiency.
Efficacy of vein obliteration was categorized as: (1)
totally occluded (TO) (ie, veins with no evidence of flow),
(2) partially occluded (PO) (ie, no evidence of flow in a vein
trunk except for a vein segment [5 cm or less in length]),
and (3) inefficiently occluded (IO) (ie, flow in a segment
greater than 5 cm in length).
Varicose veins were defined as any visible abnormally
dilated, tortuous vein. Symptom severity, limb pain, fa-
tigue, and edema were each ranked as absent (0), moderate
(1), or severe (2). The total score for each limb ranged from
zero (asymptomatic) to six (severe pain, fatigue, and ed-
ema).9 The surgeon assessing the patient rated and re-
corded these scores in the clinical notes.
RESULTS
Patient characteristics. We treated 1060 patients (in-
cluding 1186 limbs; 639 women (60%), 421 men (40%),
age 23-79 years, mean age 56 years) with endovenous laser
ablation over a 50-month period. Of the 1186 limbs, 15
had had previous sclerotherapy and another 21 had GSV
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months (mean 27 months SD of 11 months). Overall,
slightly more left legs (n 676, 57%) were treated, and 126
patients (12%) were treated for bilateral GSV reflux and
tributary varices. The disease course was 1.8 to 42 years
(mean 13.4 years). According to the CEAP (clinical, etio-
logical, anatomical, and pathological grade) classification,
all involved lower limbs had superficial varicose veins, and
54% had a class 4 or higher clinical stage.10 Patients’
demographic data and CEAP grades are listed in Table I.
Therapeutic effects. Percutaneous access and en-
dovenous placement of laser fibers were achieved in all
patients. All patients tolerated the procedure well and re-
covered uneventfully. They were encouraged to return to
ambulatory activities, normal daily activities, and work 1
day, 3 days, and 10 to 14 days, respectively, after the
operation. The diode laser fiber in the treatment of GSV
and superficial varicosities was normally 600 m in diame-
ter, and a wavelength of 810 nm was chosen in our series.
Pulses ranging in duration from 80 to 600 seconds (mean
245) were used throughout the procedure. Depending on
the severity of the varicosities, the entire procedure took 40
to 120 minutes (mean 55) to perform.
Use of EVLA plus ligation of the great saphenous vein
resulted in GSV occlusion in all cases at 2 weeks follow-up
with no flow detectable by duplex US interrogation (Table II).
At 6 months follow-up, 1169 of 1186 (99%) GSVs re-
mained closed. Of the 17 GSVs that opened, 12 were
partially occluded (PO) and five were inefficiently occluded
(IO); these patients had recurrent calf varicose veins. An-
other 19 patients also had local recurrent varicose veins,
Table I. Demographic characteristics and CEAP
classification for 1060 patients (1186 limbs) treated with
EVLA
Variable Data
History
Mean age, y (range) 56.17 (23-79)
Women/men 639/421 (60.28%/39.72%)
Limb (right/left) 676/510
Course of disease, y (range) 13.4 (1.8-42)
Previous treatment
Sclerotherapy 15 (1.26%)
Ablation 21 (1.77%)
CEAP classification
Clinical
Class 2 173 (14.59%)
Class 3 367 (30.94%)
Class 4 423 (35.67%)
Class 5 127 (10.71%)
Class 6 96 (8.09%)
Etiology
Primary 1186 (100%)
Secondary 0
Anatomy/pathology
Superficial reflux 796 (67.12%)
Deep reflux 390 (32.88%)
EVLA, Endovenous laser ablation.which were successfully treated with multiple punctureEVLA under local anesthesia. The rate of retreatment was
3% (36/1186); no recurrence was seen in other patients
after 6 months follow-up. At 6 to 9 months follow-up visit,
GSV occlusion was substantial (50% reduction in diame-
ter) and at 1 year and beyond, GSV disappeared completely
or existed as minimal residual fibrous cords with no flow
detectable. Most of the treated vein segments became
fibrose and proved to be difficult to identify. No great
saphenous veins regained patency after 1 year.
Analysis of questionnaire data on preoperative and
postoperative venous symptoms found that EVLA reduced
symptoms associated with varicose veins, such as limb pain,
fatigue, and edema (Table III). Ninety-six patients had
gaiter ulcerations, which healed in 2 to 8 weeks after the
procedure. By 6 months after initial treatment, pigmenta-
tion and pruritus were greatly improved or resolved in all
treated limbs.
Complications. Pain, ecchymosis, induration, and
phlebitis are common adverse events associated with
EVLA, but in most cases they are self-limiting. During the
early period after EVLA, 532 limbs (44.86%) experienced
ecchymosis or discoloration beneath the skin along the
course of treated veins, but this symptom usually abated in
2 to 4 weeks. In addition, 450 limbs (38%) had string-like
indurations over the treated veins that caused slight or
moderate pain and resolved in 3 to 6 weeks. Only 19
patients required treatment with over-the-counter analge-
sics (ibuprofen) for 1 to 2 weeks. Five percent of patients
developed superficial phlebitis, but most cases required no
treatment. Spot skin burn injuries occurred in 12 limbs
(1.01%) and resolved in 2 to 4 weeks. Postoperative infec-
tion occurred in seven limbs (0.59%). Paresthesia in the
Table II. Obliteration of GSV by DUS assessment
Outcome
Follow-up time
2 wk 6 mos 9 mo 12 mo or longer
N 1186 1186 1186 1186
Total occluded 1186 1169 1184 1186
Partial occluded 0 12 2 0
Inefficiently occluded 0 5 0 0
GSV, Great saphenous vein; DUS, duplex ultrasound.
Table III. Mean symptom severity scores
Follow-up
time period N
Mean pretreatment
score
Mean posttreatment
score
Pretreatment 1186 3.56 N/A
3 mo 1186 3.56 0.7
6 mo 1186 3.56 0.23
9 mo 1186 3.56 0.12
12 mo 1186 3.56 0.17
24 mo 878 3.61 0.13
36 mo 523 3.55 0.12
48 mo 135 3.58 0.08
N/A, Not applicable.gaiter area was noted in 65 limbs (5.48%) but disappeared
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complications such as deep vein thrombosis (DVT), pul-
monary embolism (PE), allergic reactions, or hematoma
developed, and all of the above-mentioned minor compli-
cations resolved without sequelae.
DISCUSSION
Percutaneous methods for treating incompetent GSVs
are not new. Duplex-guided sclerotherapy for treatment of
GSV reflux has been attempted, but long-term studies have
failed to prove long-term benefit comparable to that result-
ing from surgery.11,12 Initial attempts at damaging vein
walls by electrocoagulation involved creation of a thrombus
within the vessel lumen, but the occluded vessels ultimately
recanalized.13,14 Early methods of intraluminal delivery of
high-frequency alternating-current radiofrequency (RF)
energy to treat GSV reflux were complicated by skin burns,
saphenous nerve and peroneal nerve injury, phlebitis, and
wound infection.15,16 In 1999, Boné17 first reported on
delivery of endoluminal laser energy. Since then, a method
for treating the entire incompetent GSV segment has been
described.5,6 Sufficient heating of the vein wall is necessary
to cause collagen contraction and destruction of the endo-
thelium. This stimulates vein wall thickening, eventual
luminal contraction, and fibrosis of the vein.18 An inverse
relation exists between fluence (ie, energy density) and area
of irradiated surface, suggesting that different venous diam-
eters require variable exposure times at the same wattage to
deliver the same fluence.19 For this study, the optical fiber
retraction speed was changed (in different venous segments
of differing diameter and surface area) rather than the watts
delivered. This was practically much easier to accomplish
with the same effect. An adequate fluence should be achiev-
able in veins of varying diameter and inner surface area by
adjusting retraction speed, thereby maximizing the efficacy
of the treatment.19
Most people with varicose veins experience symptoms
of venous reflux (ie, restless legs, pain, edema, eczema,
pigmentation, and ulceration). Our results demonstrated
that EVLA could reduce and relieve these symptoms.How-
ever, for some patients, especially younger women, cos-
metic reasons for treatment are also important. In the
literature, most authors have only used endovenous laser
ablation for GSV reflux, not for tributary varicosities. Al-
though symptomatic resolution and significant improve-
ment in the appearance of the leg is usually noted after
endovenous laser ablation alone, full restoration usually
requires additional complementary procedures (ie, sclero-
therapy or phlebectomy).5,6,20 Our results revealed that
EVLA occludes both the venous trunk and tributary vari-
cosities. During the procedure, tributary varicosities are
treated by multiple puncture using a mini guidewire and
dilator. This add-on procedure increases treatment efficacy
and reduces recurrent varicose veins. Manual compression
is applied over the red aiming beam to achieve vein wall
apposition around the laser fiber tip during firing, and the
treated area is compressed several minutes after the laser
fiber is withdrawn. Longer exposure (obtained by slowingoptical fiber retraction or by repeating the laser irradia-
tion two or three times) can be used successfully in lar-
ger diameter tributary varicosities and extensive varicose
masses. So EVLA can achieve both therapeutic and cos-
metic goals.
Endovenous laser irradiation of the GSV combined
with surgical interruption of the saphenofemoral junction is
recommended.20 High ligation of the GSV was used to
decrease the risk of thrombus formation in the deep vein
and recanalization of the GSV caused by SFJ reflux and to
facilitate thrombosis and fibrosis throughout the GSV.
Clinically apparent DVT or PE was absent in our patient
cohort. In this study, all recurrences were noted before 6
months, with the majority seen by 3 months. This may
indicate that these were not true recurrences but rather the
result of inadequate initial treatment. Twelve skin burn
injuries occurred at an early stage in our series. Because
subcutaneous injections of tumescent saline and quick
withdrawal were used, such complications were seldom
seen.
The endovenous diode laser exerts its effect on contact.
We suggest that before emission of the laser energy, the
involved limbs be elevated or the treated area be com-
pressed to fully empty venous blood and collapse the ve-
nous wall. This should facilitate fiber endothelial contact
and reduce the postoperative thrombophlebitis and the
formation of indurations. Superficial thrombophlebitis
with thrombosis in the GSV would result in recanalization
of the vein.5 The higher rate of painful thrombophlebitis
and cellulitis with the EVLA technique is probably due to
incomplete vein emptying, an intraluminal thrombus, and
surrounding inflammation.21 Indurations along the course
of the GSV or over the treated varicose veins will cause local
pain. Such a tissue reaction is most distinct 1 to 2 weeks
postoperatively and then gradually subsides and diminishes
in 3 to 6 weeks. The more complete the emptying of the
vein lumen, the weaker the intensity of the tissue reaction,
and the better the results achieved. Therefore, we recom-
mend creating a near bloodless field inside the GSV by
wrapping the limb with an elastic compressive bandage and
placing the patient in the Trendelenburg position. In addi-
tion, compression bandaging or compression stockings are
most important postoperatively to avoid early recanaliza-
tion and enhance the therapeutic effect. Although we did
not monitor closely compliance with postoperative com-
pression, we believe that this may be a contributing factor
for recurrences and some complications. Because most of
our patients had varices in the calf region and more fre-
quent advanced skin changes in the gaiter area than previ-
ously reported, we treated the entire incompetent GSV
from groin to ankle (not from groin to knee) in all cases. To
avoid thermal injury to the saphenous nerve during the
procedure, a relatively quick withdrawal of the catheter and
the optical fiber (in 3- to 5-mm increments) was performed
in the GSV from the knee to ankle level.
Our results with EVLA have been impressive: very
effective closure of incompetent GSV and varicose veins,
reduction and relief of patient symptoms associated with
JOURNAL OF VASCULAR SURGERY
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rates of complications. Since this technique is continually
developing, the future outlook for its extensive application
is favorable. Vein emptying before the emission of laser
energy and compression treatment after EVLA may be
important measures.
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